Notebook

Image provided by Genzyme Transgenics Corporation CLONING GOATS In contrast to cloning's popular image as a brave new way to mass-produce monsters, biologists have described cloning as a tool to ease other biotechnologies. Researchers from Louisiana State University in Baton Rouge, Genzyme Transgenic Corp. in Framingham, Mass., and Tufts University School of Medicine in North Grafton, Mass., have shown how cloning can dramatically increase the efficiency of creating goats that secrete valuable

Written byRicki Lewis
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Image provided by Genzyme Transgenics Corporation CLONING GOATS In contrast to cloning's popular image as a brave new way to mass-produce monsters, biologists have described cloning as a tool to ease other biotechnologies. Researchers from Louisiana State University in Baton Rouge, Genzyme Transgenic Corp. in Framingham, Mass., and Tufts University School of Medicine in North Grafton, Mass., have shown how cloning can dramatically increase the efficiency of creating goats that secrete valuable biopharmaceuticals in their milk (A. Baguisi et al., "Production of goats by somatic cell nuclear transfer," Nature Biotechnology, 17:456-61, May 1999). Traditional transgenics microinjects a gene of interest into a just-fertilized egg--an effort more often miss than hit. Transfer of an already-transgenic nucleus would ensure that the offspring are female and transgenic. So following in the hoofsteps of Dolly the sheep and cloned cattle George and Charlie, the researchers transferred nuclei from cultured fetal fibroblasts into enucleated oocytes. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies